National and regional prevalence of posttraumatic stress disorder in sub-Saharan Africa: A systematic review and meta-analysis.
Journal
PLoS medicine
ISSN: 1549-1676
Titre abrégé: PLoS Med
Pays: United States
ID NLM: 101231360
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
02
08
2019
accepted:
13
04
2020
entrez:
16
5
2020
pubmed:
16
5
2020
medline:
25
7
2020
Statut:
epublish
Résumé
People living in sub-Saharan Africa (SSA) are disproportionately exposed to trauma and may be at increased risk for posttraumatic stress disorder (PTSD). However, a dearth of population-level representative data from SSA is a barrier to assessing PTSD. This manuscript sought to calculate pooled PTSD prevalence estimates from nationally and regionally representative surveys in SSA. The search was conducted in PubMed, Embase, PsycINFO, and PTSDpubs and was last run between October 18, 2019, and November 11, 2019. We included studies that were published in peer-reviewed journals; used probabilistic sampling methods and systematic PTSD assessments; and included ≥ 450 participants who were current residents of an SSA country, at least 50% of whom were aged between 15 and 65 years. The primary outcomes were point prevalence estimates of PTSD across all studies, and then within subgroups. The protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO) (registration number CRD42016029441). Out of 2,825 unique articles reviewed, 25 studies including a total of 58,887 eligible participants (54% female) in 10 out of the 48 countries in SSA were identified. Most studies enrolled any adult aged 18 years or older. However, some studies only enrolled specific age brackets or persons as young as 15 years old. Six studies were national surveys, and 19 were regional. There were 4 key findings in the meta-analysis: (1) the overall pooled prevalence of probable PTSD was 22% (95% CI 13%-32%), while the current prevalence-defined as 1 week to 1 month-was 25% (95% CI 16%-36%); (2) prevalence estimates were highly variable, ranging from 0% (95% CI 0%-0%) to 74% (95% CI 72%-76%); (3) conflict-unexposed regions had a pooled prevalence of probable PTSD of 8% (95% CI 3%-15%), while conflict-exposed regions had a pooled prevalence of probable PTSD of 30% (95% CI 21%-40%; p < 0.001); and (4) there was no significant difference in the pooled prevalence of PTSD for men and women. The primary limitations of our methodology are our exclusion of the following study types: those published in languages other than English, French, and Portuguese; smaller studies; those that focused on key populations; those that reported only on continuous measures of PTSD symptoms; and unpublished or non-peer-reviewed studies. In this study, PTSD symptoms consistent with a probable diagnosis were found to be common in SSA, especially in regions exposed to armed conflict. However, these studies only represent data from 10 of the 48 SSA countries, and only 6 studies provided national-level data. Given the enormous heterogeneity expected across the continent, and also within countries and regions, this review cannot speak to rates of PTSD in any regions not included in this review. Thus, substantial gaps in our knowledge of PTSD prevalence in SSA remain. More research on population-level prevalence is needed to determine the burden of trauma symptoms and PTSD in SSA and to identify acceptable and feasible approaches to address this burden given limited mental healthcare resources.
Sections du résumé
BACKGROUND
People living in sub-Saharan Africa (SSA) are disproportionately exposed to trauma and may be at increased risk for posttraumatic stress disorder (PTSD). However, a dearth of population-level representative data from SSA is a barrier to assessing PTSD. This manuscript sought to calculate pooled PTSD prevalence estimates from nationally and regionally representative surveys in SSA.
METHODS AND FINDINGS
The search was conducted in PubMed, Embase, PsycINFO, and PTSDpubs and was last run between October 18, 2019, and November 11, 2019. We included studies that were published in peer-reviewed journals; used probabilistic sampling methods and systematic PTSD assessments; and included ≥ 450 participants who were current residents of an SSA country, at least 50% of whom were aged between 15 and 65 years. The primary outcomes were point prevalence estimates of PTSD across all studies, and then within subgroups. The protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO) (registration number CRD42016029441). Out of 2,825 unique articles reviewed, 25 studies including a total of 58,887 eligible participants (54% female) in 10 out of the 48 countries in SSA were identified. Most studies enrolled any adult aged 18 years or older. However, some studies only enrolled specific age brackets or persons as young as 15 years old. Six studies were national surveys, and 19 were regional. There were 4 key findings in the meta-analysis: (1) the overall pooled prevalence of probable PTSD was 22% (95% CI 13%-32%), while the current prevalence-defined as 1 week to 1 month-was 25% (95% CI 16%-36%); (2) prevalence estimates were highly variable, ranging from 0% (95% CI 0%-0%) to 74% (95% CI 72%-76%); (3) conflict-unexposed regions had a pooled prevalence of probable PTSD of 8% (95% CI 3%-15%), while conflict-exposed regions had a pooled prevalence of probable PTSD of 30% (95% CI 21%-40%; p < 0.001); and (4) there was no significant difference in the pooled prevalence of PTSD for men and women. The primary limitations of our methodology are our exclusion of the following study types: those published in languages other than English, French, and Portuguese; smaller studies; those that focused on key populations; those that reported only on continuous measures of PTSD symptoms; and unpublished or non-peer-reviewed studies.
CONCLUSIONS
In this study, PTSD symptoms consistent with a probable diagnosis were found to be common in SSA, especially in regions exposed to armed conflict. However, these studies only represent data from 10 of the 48 SSA countries, and only 6 studies provided national-level data. Given the enormous heterogeneity expected across the continent, and also within countries and regions, this review cannot speak to rates of PTSD in any regions not included in this review. Thus, substantial gaps in our knowledge of PTSD prevalence in SSA remain. More research on population-level prevalence is needed to determine the burden of trauma symptoms and PTSD in SSA and to identify acceptable and feasible approaches to address this burden given limited mental healthcare resources.
Identifiants
pubmed: 32413027
doi: 10.1371/journal.pmed.1003090
pii: PMEDICINE-D-19-02823
pmc: PMC7228043
doi:
Types de publication
Journal Article
Meta-Analysis
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1003090Subventions
Organisme : NIMH NIH HHS
ID : K23 MH110601
Pays : United States
Organisme : NIMH NIH HHS
ID : T32 MH093310
Pays : United States
Organisme : Department of Health
ID : GHRU 16/136/54
Pays : United Kingdom
Commentaires et corrections
Type : ErratumIn
Déclaration de conflit d'intérêts
C.H. is a member of the Editorial Board of PLOS Medicine.
Références
Eur J Psychotraumatol. 2017 Oct 27;8(sup5):1353383
pubmed: 29075426
S Afr Med J. 2009 May;99(5 Pt 2):339-44
pubmed: 19588796
Lancet. 2007 Sep 8;370(9590):841-50
pubmed: 17826169
BMC Public Health. 2013 May 14;13:469
pubmed: 23672785
Soc Psychiatry Psychiatr Epidemiol. 2010 Mar;45(3):405-12
pubmed: 19479171
Eur J Psychotraumatol. 2019 Feb 22;10(1):1578637
pubmed: 30834069
Int J Environ Res Public Health. 2015 Oct 26;12(10):13494-509
pubmed: 26516877
Lancet. 2013 Nov 9;382(9904):1575-86
pubmed: 23993280
PLoS One. 2018 Jun 7;13(6):e0198429
pubmed: 29879167
Lancet. 2015 Aug 22;386(9995):743-800
pubmed: 26063472
BMC Psychiatry. 2009 May 16;9:23
pubmed: 19445689
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
JAMA. 2004 Aug 4;292(5):602-12
pubmed: 15292086
PLoS One. 2014 Jul 23;9(7):e102786
pubmed: 25054324
Soc Sci Med. 2013 Jan;77:41-9
pubmed: 23219850
Glob Public Health. 2015 Jan;10(1):55-70
pubmed: 25363537
Int J Environ Res Public Health. 2012 May;9(5):1748-56
pubmed: 22754470
Matern Child Health J. 2014 Jan;18(1):191-199
pubmed: 23467845
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Soc Psychiatry Psychiatr Epidemiol. 2017 Jun;52(6):705-714
pubmed: 28401274
Psychol Med. 2008 Feb;38(2):211-20
pubmed: 17903333
Psychol Assess. 2010 Jun;22(2):318-24
pubmed: 20528059
PLoS One. 2017 Apr 6;12(4):e0175240
pubmed: 28384241
BMJ Open. 2015 Jun 24;5(6):e006778
pubmed: 26109109
Soc Sci Med. 2008 Aug;67(3):441-52
pubmed: 18486292
BMC Psychiatry. 2015 Jul 24;15:170
pubmed: 26205192
Confl Health. 2009 May 26;3:6
pubmed: 19470171
J Nerv Ment Dis. 2002 Sep;190(9):631-7
pubmed: 12357098
JAMA. 2010 Aug 4;304(5):553-62
pubmed: 20682935
J Child Psychol Psychiatry. 2010 Oct;51(10):1096-104
pubmed: 20345839
Psychol Med. 2017 Oct;47(13):2260-2274
pubmed: 28385165
AIDS Care. 2011 Sep;23(9):1128-35
pubmed: 21480009
Lancet. 2011 Oct 29;378(9802):1592-603
pubmed: 22008429
Am J Psychiatry. 2005 Sep;162(9):1713-22
pubmed: 16135632
Soc Psychiatry Psychiatr Epidemiol. 2011 Jan;46(1):59-67
pubmed: 19921080
BMC Psychiatry. 2008 May 19;8:38
pubmed: 18489768
J Clin Epidemiol. 2010 Oct;63(10):1061-70
pubmed: 20728045
BMC Psychiatry. 2012 Jun 18;12:63
pubmed: 22713589
Psychol Trauma. 2017 May;9(3):274-281
pubmed: 28459270
Int J Soc Psychiatry. 2013 Dec;59(8):782-8
pubmed: 22982816
Soc Psychiatry Psychiatr Epidemiol. 2008 Sep;43(9):736-42
pubmed: 18465102
BJOG. 2006 Mar;113(3):284-8
pubmed: 16487199
Lancet. 2014 May 10;383(9929):1648-1654
pubmed: 24529867
Afr Health Sci. 2016 Dec;16(4):1027-1035
pubmed: 28479896
PLoS Med. 2012;9(12):e1001359
pubmed: 23300387
Chronic Dis Can. 1998;19(4):170-6
pubmed: 10029513
Soc Psychiatry Psychiatr Epidemiol. 2012 Nov;47(11):1753-61
pubmed: 22402589
Br J Psychiatry. 2004 Feb;184:169-75
pubmed: 14754831
Afr J Med Med Sci. 2011 Mar;40(1):23-31
pubmed: 21834258
Depress Anxiety. 2017 Apr;34(4):315-326
pubmed: 27921352
Int J Epidemiol. 2009 Aug;38(4):1033-45
pubmed: 19204009
BJOG. 2013 Jul;120(8):940-6
pubmed: 23464524
J Affect Disord. 2013 Nov;151(2):715-21
pubmed: 24012069
JAMA. 2008 Aug 13;300(6):676-90
pubmed: 18698066
Br J Psychiatry. 2016 Oct;209(4):300-305
pubmed: 27445357
PLoS One. 2012;7(5):e36304
pubmed: 22606252
Int J Methods Psychiatr Res. 2004;13(2):93-121
pubmed: 15297906
J Anxiety Disord. 2015 May;32:8-16
pubmed: 25840139
Arch Pediatr Adolesc Med. 2009 Jun;163(6):525-30
pubmed: 19487608
BMC Psychol. 2014 Aug 31;2(1):31
pubmed: 25685351
Cent Afr J Med. 2003 Jul-Aug;49(7-8):78-83
pubmed: 15214278
Sci Transl Med. 2014 Sep 10;6(253):253cm9
pubmed: 25210058
Afr Health Sci. 2004 Aug;4(2):83-93
pubmed: 15477186
Trauma Violence Abuse. 2020 Apr;21(2):406-420
pubmed: 29699456
J Trauma Stress. 2015 Aug;28(4):375-9
pubmed: 26271019
Psychol Med. 1997 Jan;27(1):153-60
pubmed: 9122295
Arch Public Health. 2014 Nov 10;72(1):39
pubmed: 25810908
JAMA. 1999 Aug 4;282(5):433-9
pubmed: 10442658
Soc Psychiatry Psychiatr Epidemiol. 2004 Jun;39(6):442-7
pubmed: 15205728
BMC Womens Health. 2014 Sep 06;14:106
pubmed: 25195041
PLoS Med. 2016 Aug 09;13(8):e1002073
pubmed: 27505186
Public Health. 2006 Jun;120(6):534-42
pubmed: 16684549
PLoS One. 2013 Jun 24;8(6):e65514
pubmed: 23826081
BMC Psychiatry. 2015 Mar 14;15:48
pubmed: 25881310
Am J Public Health. 2010 Sep;100(9):1745-51
pubmed: 20634461
J Clin Psychiatry. 2000;61 Suppl 5:4-12; discussion 13-4
pubmed: 10761674
BMC Psychiatry. 2009 Mar 04;9:7
pubmed: 19261192
Lancet. 2019 Jul 20;394(10194):240-248
pubmed: 31200992
JAMA. 2007 Aug 1;298(5):543-54
pubmed: 17666675
Am J Orthopsychiatry. 2010 Apr;80(2):227-36
pubmed: 20553516
Psychol Med. 2017 Jan;47(2):227-241
pubmed: 27573281
Soc Sci Med. 2012 Aug;75(3):548-54
pubmed: 22580073
BMC Psychiatry. 2016 Jun 24;16:202
pubmed: 27342048
Psychol Health Med. 2013;18(4):387-97
pubmed: 23061988
PLoS One. 2013 Oct 04;8(10):e74771
pubmed: 24124455
BMC Psychiatry. 2013 Jul 03;13:182
pubmed: 23819543
Lancet. 2007 Sep 8;370(9590):878-89
pubmed: 17804062
Arch Gen Psychiatry. 1988 Dec;45(12):1069-77
pubmed: 2848472
Br J Psychiatry. 2002 Aug;181:158-62
pubmed: 12151288
BMJ Glob Health. 2018 Mar 17;3(2):e000471
pubmed: 29607096
S Afr Med J. 2009 May;99(5 Pt 2):396-402
pubmed: 19588804
Spine (Phila Pa 1976). 2010 Mar 15;35(6):684-9
pubmed: 20139812
Int J Psychiatry Med. 2015;50(3):299-316
pubmed: 26561275
Br J Psychiatry. 2006 May;188:465-71
pubmed: 16648534
Int J Soc Psychiatry. 2015 Jun;61(4):363-72
pubmed: 25145869
Int J Epidemiol. 2014 Apr;43(2):365-406
pubmed: 24366490
J Affect Disord. 2018 Oct 15;239:328-338
pubmed: 30031252
PLoS One. 2019 Apr 12;14(4):e0215052
pubmed: 30978228
S Afr J Psychiatr. 2019 Oct 21;25:1329
pubmed: 31745437
Depress Anxiety. 2014 Feb;31(2):130-42
pubmed: 23983056
BMJ Open. 2019 Jun 29;9(6):e028550
pubmed: 31256034
Int J Psychiatry Med. 2013;46(4):387-405
pubmed: 24922989
Br J Psychiatry. 2008 Feb;192(2):112-7
pubmed: 18245026
Biol Psychiatry. 2015 Feb 15;77(4):375-84
pubmed: 24842116
JAMA. 2001 Aug 1;286(5):555-62
pubmed: 11476657
Soc Sci Med. 2002 Oct;55(7):1231-44
pubmed: 12365533
Child Abuse Negl. 2014 Jan;38(1):135-46
pubmed: 24239222
Glob Ment Health (Camb). 2016 Feb 10;3:e4
pubmed: 28596873
BMC Psychiatry. 2012 Oct 19;12:175
pubmed: 23083301
BMC Psychiatry. 2014 Jan 10;14:6
pubmed: 24410951
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120